Ramani, Shyama V., and Eduardo Urias. “When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil.” Research Policy 47.8 (2018): 1538-1552. (pdf)
Ramani, S. V., Thutupalli, A., El-Aroui, M. A., & Kumar, P. (2017). MNE Led New Market Creation in Emerging Countries: The Case of Bt Cotton. In Multinational Enterprises and Sustainable Development(pp. 131-150). Emerald Publishing Limited. (pdf)
“Emergence of Controversy in Technology Transitions: Green Revolution and Bt cotton in India”, with Ajay Thutupalli Technological Forecasting and Social Change, 100, 198–212 (2015). (pdf)
“Access to Critical Medicines: When are compulsory licenses effective in price negotiations?” with Eduardo Urias, Social Science & Medicine, 135, 75-83 (2015). (pdf)
Reid SE, Coronini R, Ramani SV. On Nanoscience, Nanotechnology, and Nanoproducts: Why Everyone Wants to Join This Game?. In Nanotechnology and Development: What’s in It for Emerging Countries? Edited by Ramani S. V., 2014 (pp. 3-38). Cambridge University Press. (pdf )
Vinck, D., and S.V. Ramani. “How is a regional technology cluster created? Insight from the construction of the nanotech cluster in Grenoble.” In Nanotechnology and Development: What’s in it for Emerging Countries? Edited by S.V. Ramani (2014): 73-92. (pdf )
Notten, Ad, and Shyama V. Ramani. “Co-patenting patterns in nanotechnology.” In book edited by Shyama V. Ramani, Nanotechnology and Development: What’s in it for Emerging Countries
(2014): 93-120. (pdf)
Ramani, Shyama V., and Jorge Niosi. “Nanotech after Biotech in Emerging Economies: Déjà Vu or a New Form of Catching Up?.” In book edited by Ramani, Shyama V. ,Nanotechnology and Development: What’s in It for Emerging Countries?. Cambridge University Press, 2015. 241-258. (pdf)
“The harnessing of biotechnology in India: Which roads to travel?” with S.Reid Technological Forecasting and Social Change.79 (4), 648–664, May 2012.(pdf)
“Explaining divergence in catching-up in pharmaceuticals between India and Brazil using the NSI framework” with S. Guennif, Research Policy. 41, 430-441 (2012).(pdf)
“Experimentation with strategy and evolution of dynamic capability in the Indian Pharmaceutical sector” with S.Athreye and D. Kale. Industrial and Corporate Change 18(4):729-759, (2009).( pdf )
“La propriété intellectuelle : Un boulet pour les pays émergents”, Le Monde, (March 15, 2005).(pdf )
“TRIPS and its possible impact on the biotech based segment of the Indian pharmaceutical industry”, with A. Maria, Economic and Political Weekly, Feb 12-18, 675-683,(Feb, 2005).(pdf)
“Biotech in post TRIPS India” with P. Pradhan and M.Ravi, Nature Biotechnology, Volume 23, no.1, 18-19, (Jan, 2005).(pdf)
“Who’s interested in biotechnology: R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms” Research Policy vol. 31, 381-398 (2002).(pdf)
“Rising to the technological challenge: Integration of biotechnology in the Indian Pharmaceutical Industry” with M.S. Venkataramani, International Journal of Biotechnology, vol 3, no. 1/2, 95-115, (2001). (pdf)
“Resources, performance and strategy: a statistical examination of the integration of biotechnology in the Indian pharmaceutical sector”, with C. Putz, International Journal of Biotechnology, vol. 3, no.3/4, 374-390, (2001).(pdf )
“Introduction to the special issue on biotechnology” International Journal of Biotechnology vol 3, no. 1/2, 1-3, (2001). (pdf)
“The role of resources and incentives in the integration of biotechnology in developing countries : An Indian case study” with Visalakshi, International Journal of Biotechnology, vol. 2, no. 4, 297-312, (2001). (pdf)
“Biotechnologies: l’Inde monte en puissance”, Biofutur, 174, (January 1998), 18-21. (pdf)